See also this year's filing and all EDGAR filings for this company.
PDF Report 0000316253_2014_ENZO_Biochem_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.006708702984089742, 'aggregate_val': 27461000, 'exp_sum': 27278000, 'exp_to_value': {'LongTermLiabilities': 2313000, 'LiabilitiesCurrent': 24965000, 'remainder_Liabilities': 0}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.008121497604158206, 'aggregate_val': 24826000, 'exp_sum': 24626000, 'exp_to_value': {'LongTermLiabilities': 774000, 'LiabilitiesCurrent': 23852000, 'remainder_Liabilities': 0}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000316253')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000316253, ENZO Biochem INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 17,395,000 |
| 1 | AssetsNonCurrent | 390,000 |
| 2 | AssetsCurrent | 32,556,000 |
| 3 | PropertyPlantAndEquipment | 8,617,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 774,000 |
| 6 | LiabilitiesCurrent | 23,852,000 |
| 7 | remainder_Liabilities | 200,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 43,654,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 3,889,000 |
| 16 | remainder_Expenses | 64,432,000 |
| 17 | remainder_Revenues | 93,707,000 |
| 18 | remainder_NetIncome | 31,000 |
| 19 | remainder_ComprehensiveNetIncome | 253,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 58,958,000 |
| 1 | Liabilities | 24,826,000 |
| 2 | Expenses | 111,975,000 |
| 3 | Revenues | 93,707,000 |
| 4 | StockholdersEquity | 34,132,000 |
| 5 | NetIncome | -18,237,000 |
| 6 | ComprehensiveNetIncome | -17,984,000 |
| 7 | BaseVar | 144,875,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.752 |
| 9 | EconomicCapitalRatio | 1.53 |
Edgar->Model Mapping
Feature Distribution
Change over Time
